Severe asthma has a great impact on the quality of life (QOL) of patients and their families.
The magnitude of this morbidity is affected by several personal factors including age …

Asthma exacerbations are an important cause of asthma morbidity. Although viral infection
of the upper airway is a common cause of asthma exacerbations, the reasons why some …

It is largely unrecognised that the impacts of asthma are different in patients with severe
disease compared with patients with mild to moderate disease.• Severe asthma is …

Cost-utility models are increasingly used in many countries to establish whether the cost of a
new intervention can be justified in terms of health benefits. Health-state utility (HSU) …

OBJECTIVE: To evaluate the 16-and 52-week effectiveness of add-on omalizumab
treatment under real-life heterogeneity in patients, settings, and physicians in an open-label …

Rationale: Asthma is heterogeneous and knowledge on exacerbation patterns is lacking.
Previous studies have had a relatively short follow-up or focused on severe disease …

Asthma is a heterogeneous lung disease, usually characterised by chronic airway
inflammation. Although evidence-based treatments are available in most countries, asthma …

Background People with asthma may experience exacerbations or" attacks" during which
their symptoms worsen and additional treatment is required. Written action plans may …

Background Few data are available that evaluate the relationship among asthma
exacerbations, asthma triggers, and asthma-related quality of life (QoL). Objective To …

Background Cigarette smoking is one of the leading causes of early death. Varenicline
[Champix (UK), Pfizer Europe MA EEIG, Brussels, Belgium; or Chantix (USA), Pfizer Inc …